Last updated: February 27, 2025
Sponsor: University of Texas Southwestern Medical Center
Overall Status: Completed
Phase
N/A
Condition
Mild Cognitive Impairment
Memory Loss
Alzheimer's Disease
Treatment
Active Transcranial direct current stimulation (STARStim 8)
Sham Transcranial direct current stimulation (STARStim 8)
Clinical Study ID
NCT05270408
STU-2021-0974
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 50 and older
Fluent in English
Active diagnosis of MCI or dementia
Exclusion
Exclusion Criteria:
Substance use disorder
Has metal fragments in head
Taking medications that may interact with the HD-tDCS effect (i.e., amphetamines,L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, dextromethorphan,D-cycloserine, flunarizine, or ropinirole)
Study Design
Total Participants: 33
Treatment Group(s): 2
Primary Treatment: Active Transcranial direct current stimulation (STARStim 8)
Phase:
Study Start date:
July 13, 2022
Estimated Completion Date:
February 15, 2024
Study Description
Connect with a study center
UT Southwestern Medical Center
Dallas, Texas 75390
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.